Bone Biologics Corporation announced a 1-for-6 reverse stock split of its common shares, effective June 10, 2025. The company's shares will trade on a post-split basis under the symbol "BBLG" on Nasdaq. The split consolidates every six existing shares into one, while maintaining stockholders' percentage ownership unchanged. The authorized share count remains the same, with a new CUSIP number assigned.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.